| Topotecan–tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential T Khuroo, D Verma, S Talegaonkar, S Padhi, AK Panda, Z Iqbal International journal of pharmaceutics 473 (1-2), 384-394, 2014 | 98 | 2014 |
| Revisiting the nanoformulation design approach for effective delivery of topotecan in its stable form: an appraisal of its in vitro Behavior and tumor amelioration … S Padhi, MA Mirza, D Verma, T Khuroo, AK Panda, S Talegaonkar, ... Drug Delivery 23 (8), 2827-2837, 2016 | 65 | 2016 |
| Design expert assisted nanoformulation design for co-delivery of topotecan and thymoquinone: Optimization, in vitro characterization and stability assessment D Verma, PS Thakur, S Padhi, T Khuroo, S Talegaonkar, Z Iqbal Journal of Molecular Liquids 242, 382-394, 2017 | 64 | 2017 |
| Preparation, evaluation and pharmacokinetic studies of spray dried PLGA polymeric submicron particles of simvastatin for the effective treatment of breast cancer N Anzar, MA Mirza, K Anwer, T Khuroo, AS Alshetaili, SM Alshahrani, ... Journal of Molecular Liquids 249, 609-616, 2018 | 54 | 2018 |
| Simultaneous delivery of paclitaxel and erlotinib from dual drug loaded PLGA nanoparticles: Formulation development, thorough optimization and in vitro release T Khuroo, D Verma, A Khuroo, A Ali, Z Iqbal Journal of Molecular Liquids 257, 52-68, 2018 | 48 | 2018 |
| Glial cell: a potential target for cellular and drug based therapy in various CNS diseases S Ahmed, A Gull, T Khuroo, M Aqil, Y Sultana Current pharmaceutical design 23 (16), 2389-2399, 2017 | 21 | 2017 |
| Microneedle technology: a new drug delivery system N Tabassum, A Sofi, T Khuroo Int J Res Pharm Biomed Sci 2 (1), 59-62, 2011 | 18 | 2011 |
| Ultra-long acting prodrug of dolutegravir and delivery system–physicochemical, pharmacokinetic and formulation characterizations T Khuroo, S Dharani, EM Mohamed, S Immadi, Z Wu, MA Khan, D Lu, ... International Journal of Pharmaceutics 607, 120889, 2021 | 14 | 2021 |
| Very-rapidly dissolving printlets of isoniazid manufactured by SLS 3D printing: in vitro and in vivo characterization T Khuroo, EM Mohamed, S Dharani, C Kayalar, T Ozkan, ... Molecular pharmaceutics 19 (8), 2937-2949, 2022 | 13 | 2022 |
| Nanopotentiated combination cancer therapy: Chemotherapeutic and chemosensitizer (2C approach) D Verma, T Khuroo, S Talegaonkar, Z Iqbal Medical Hypotheses 84 (6), 580-582, 2015 | 13 | 2015 |
| In-use stability assessment of FDA approved metformin immediate release and extended release products for N-Nitrosodimethylamine and dissolution quality attributes S Dharani, EM Mohamed, T Khuroo, HI Ali, IK Reddy, Z Rahman, ... International Journal of Pharmaceutics 623, 121923, 2022 | 9 | 2022 |
| Formulation characterization and pharmacokinetic evaluation of amorphous solid dispersions of dasatinib S Dharani, EM Mohamed, T Khuroo, Z Rahman, MA Khan Pharmaceutics 14 (11), 2450, 2022 | 8 | 2022 |
| Revisiting the nanoformulation design approach for effective delivery of topotecan in its stable form: an appraisal of its in vitro behavior and tumor amelioration potential … S Padhi, M Mirza, D Verma, T Khuroo, A Panda, S Talegaonkar | 8 | 2015 |
| Raw materials, technology, healthcare applications, patent repository and clinical trials on 4D printing technology: An updated review MS Khan, SA Khan, S Shabbir, M Umar, S Mohapatra, T Khuroo, ... Pharmaceutics 15 (1), 116, 2022 | 7 | 2022 |
| Oral formulation of paclitaxel and erlotinib polymeric nanoparticles: a potential combination to treat breast cancer T Khuroo, U Atifa, Z Iqbal Biomed J. Sci. & Tech Res.| BJSTR 31 (4), 24338-24340, 2020 | 7 | 2020 |
| Qbd based and Box-Behnken design assisted Oral delivery of stable lactone (active) form of Topotecan as PLGA nanoformulation: Cytotoxicity, pharmacokinetic, in vitro, and ex … T Khuroo, A Khuroo, A Hussain, MA Mirza, AK Panda, J Wani, Z Iqbal Journal of Drug Delivery Science and Technology 77, 103850, 2022 | 6 | 2022 |
| Preparation and characterization of dicarboxylic acids salt of aripiprazole with enhanced physicochemical properties A Hamideh, Z Rahman, S Dharani, T Khuroo, EM Mohamed, MTH Nutan, ... Pharmaceutical Development and Technology 26 (4), 455-463, 2021 | 6 | 2021 |
| In-situ implant formulation of laurate and myristate prodrugs of dolutegravir for ultra-long delivery T Khuroo, EM Mohamed, S Dharani, S Immadi, MTH Nutan, D Lu, HI Ali, ... Journal of Pharmaceutical Sciences 111 (8), 2312-2321, 2022 | 5 | 2022 |
| An insight of various vesicular systems, erythrosomes, and exosomes to control metastasis and cancer M Patil, A Hussain, MA Altamimi, S Ashique, N Haider, A Faruk, T Khuroo, ... Advances in Cancer Biology-Metastasis, 100103, 2023 | 4 | 2023 |
| Understanding of PSA biology, factors affecting PSA detection, challenges, various biomarkers, methods, and future perspective of prostate cancer detection and diagnosis T Khan, MA Altamimi, A Hussain, M Ramzan, S Ashique, MR Alhuzani, ... Advances in Cancer Biology-Metastasis 5, 100059, 2022 | 4 | 2022 |
Dr. Zeenat IqbalDepartment of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia HamdardVerified email at jamiahamdard.ac.in
